COMMUNIQUÉS West-GlobeNewswire

GN Store Nord A/S - Notice to convene the Annual General Meeting 2025
17/02/2025
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 12, 2025, at 10:00 a.m. CET at the company’s address: Lautrupbjerg 7, 2750 Ballerup, Denmark. Please find attached the notice to convene the Annual [...]
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
17/02/2025
First in market to o ffe r A djustable T ensioning T echnology * for i nsertional A chilles r econstruction and l ateral a nkle i nstability r epair *After anchor insertion Smith+Nephew (LSE:SN, NYSE:SNN), the global [...]
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
16/02/2025
MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient using CRISPR-based gene-editing [...]
REPEAT/MEDIA ADVISORY - Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario
15/02/2025
TORONTO, OTTAWA, LONDON and WINDSOR, Ontario, Feb. 15, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition is holding press conferences with patients who have been charged for cataract surgeries or manipulated into [...]
PacBio Grants Equity Incentive Award to New Employee
15/02/2025
MENLO PARK, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s [...]
UPDATE: Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
15/02/2025
WASHINGTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- A broad coalition of patient organizations today issued the following statement in response to cuts in staff, and research funding at federal agencies vital for American [...]
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
15/02/2025
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, [...]
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
15/02/2025
WASHINGTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- A broad coalition of patient organizations today issued the following statement in response to cuts in staff, and research funding at federal agencies vital for American [...]
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
14/02/2025
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers. On track for commercial launch in the U.S. in the first half of 2025. A [...]
Pennant Announces Fourth Quarter and Full Year 2024 Earnings Release and Call
14/02/2025
EAGLE, Idaho, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Codexis Announces New Employment Inducement Grants
14/02/2025
REDWOOD CITY, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of [...]
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
14/02/2025
Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced key pipeline programs, engaged regulatory authorities on ATI-1801 and preparing ATI-1701 for an Investigational New [...]
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
14/02/2025
CARLSBAD, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
14/02/2025
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported [...]
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
14/02/2025
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on February 10, 2025, [...]
GENFIT annonce la modification des termes définitifs de la double proposition aux porteurs d’OCEANEs 2025
14/02/2025
Pour faire suite (i) à son annonce du 30 janvier 2025 sur l’accord de financement non dilutif de partage de redevances ( royalty financing ) avec HealthCare Royalty (HCRx) et (ii) à son annonce des termes définitifs de [...]
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
14/02/2025
- Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker of Functional [...]
NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
14/02/2025
TORONTO and HAIFA, Israel, Feb. 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“ NurExone ” or the “ Company ”) is excited to announce that it will be presenting at the [...]
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/02/2025
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]

Pages